You are looking for

The new MedTech Europe Code of Ethical Business Practice (the “Code”) came in force on the 1st January 2017 and replaces the Eucomed Code of Ethical Business Practices and the EDMA Code of Ethics. The Code allows for an additional year to phase out direct sponsorship by the entire medtech industry but this may be […]

“All men make mistakes, but a good man yields when he knows his course is wrong, and repairs the evil. The only crime is pride.”— Sophocles, Antigone Just two decades ago, in the late ‘90s, the Institute of Medicine presented shocking statistics, comparing the death occurring from medical errors to the equivalent of a jumbo jet crashing every […]

For several years now, the Global Initiative for Asthma (GINA) has maintained the same theme for World Asthma Day: “You Can Control Your Asthma”. It is an empowering message for people living with asthma, one of Europe’s major chronic diseases affecting 30 million citizens, of which 6 million live with severe asthma symptoms. Asthma is […]

As a compliance professional, it’s exciting to witness new Codes of Ethics take root worldwide.  Voluntary industry Codes of Ethics serve several important functions.  A credible Code demonstrates industry’s ability to self-regulate, in turn fostering consumer and governmental trust and confidence.  A Code centers stakeholders on the most meaningful business principles that the entire industry […]

At W.L. Gore we took the decision to review our educational strategy well before the recommendation of the EDMA and Eucomed Boards to phase-out direct sponsorship of Healthcare Professionals (HCPs) to third party organised educational events was announced. We did this as our business leaders were getting increasingly concerned about the complexities of doing business […]

If the activities of the medical technology industry are viewed through the prism of either corruption or honesty, then the draft MedTech Europe Code of Ethical Business Practice could be considered as an endeavor to dissociate the industry from the former.  The draft code does so by providing a clear and stringent framework, ensuring that […]

Eight years ago, I was interviewing executives of a prospective Chinese distributor for my employer, a publicly-traded medical device company based in California. “We understand that it is hard to do business in China without paying kickbacks to physicians and hospital administrators” I observed. “How do you handle this?” Without hesitating, one of the executives […]

This time last year, I wrote a blogpost about the priorities MedTech Europe would be working on in 2014. This year, I’ve decided to take a different approach. Based on what I see, hear and read every day, I’ll outline what I believe to be the major medtech trends, topics and evolutions we’ll be talking […]

Yesterday, EDMA and Eucomed announced recommendations to respective members on how to improve their Codes of Ethical Business Practice. Chief among their recommendations are a phase out of direct sponsorship and stricter guidelines for indirect sponsorship of healthcare professionals to attend third-party organised conferences. They’ve also committed to working with stakeholders to elaborate new models […]